1. Superficial thrombophlebitis in ipsilateral breast after COVID-19 vaccination
- Author
-
Shima Aran, MD, Orest O. Kayder, DO, MA, Teena Chopra, MD, MPH, and Hani Abujudeh, MD, MBA
- Subjects
COVID ,mRNA vaccination ,COVID19 vaccine ,superficial thrombophlebitis ,Mondor’s disease ,Medical physics. Medical radiology. Nuclear medicine ,R895-920 - Abstract
On December 2020, the US Food and Drug Administration issued the first emergency use authorization for a vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We report development of superficial thrombophlebitis in the ipsilateral breast of a 43-year-old female 7 days after receiving the first dose of the Pfizer-BioNTech COVID-19 vaccine. Given that this is the first case of superficial thrombophlebitis in the breast shortly after mRNA vaccination for COVID-19 reported to our knowledge, we suggest that this may be a rare vaccine-related event.
- Published
- 2022
- Full Text
- View/download PDF